Kirtane AR - Search Results

1

Intranasal delivery of liposomal indole-3-carbinol improves its pulmonary bioavailability.

Song JM, Kirtane AR, Upadhyaya P, Qian X, Balbo S, Teferi F, Panyam J, Kassie F. Song JM, et al. Among authors: kirtane ar. Int J Pharm. 2014 Dec 30;477(1-2):96-101. doi: 10.1016/j.ijpharm.2014.10.018. Epub 2014 Oct 11. Int J Pharm. 2014. PMID: 25311179 Free PMC article.

2

Exploiting nanotechnology to overcome tumor drug resistance: Challenges and opportunities.

Kirtane AR, Kalscheuer SM, Panyam J. Kirtane AR, et al. Adv Drug Deliv Rev. 2013 Nov;65(13-14):1731-47. doi: 10.1016/j.addr.2013.09.001. Epub 2013 Sep 10. Adv Drug Deliv Rev. 2013. PMID: 24036273 Free PMC article. Review.

3

Polymer nanoparticles: Weighing up gene delivery.

Kirtane AR, Panyam J. Kirtane AR, et al. Nat Nanotechnol. 2013 Nov;8(11):805-6. doi: 10.1038/nnano.2013.234. Nat Nanotechnol. 2013. PMID: 24202534 No abstract available.

4

Enhanced photodynamic therapy and effective elimination of cancer stem cells using surfactant-polymer nanoparticles.

Usacheva M, Swaminathan SK, Kirtane AR, Panyam J. Usacheva M, et al. Among authors: kirtane ar. Mol Pharm. 2014 Sep 2;11(9):3186-95. doi: 10.1021/mp5003619. Epub 2014 Aug 6. Mol Pharm. 2014. PMID: 25061685

5

Reformulating Tylocrebrine in Epidermal Growth Factor Receptor Targeted Polymeric Nanoparticles Improves Its Therapeutic Index.

Kirtane AR, Wong HL, Guru BR, Lis LG, Georg GI, Gurvich VJ, Panyam J. Kirtane AR, et al. Mol Pharm. 2015 Aug 3;12(8):2912-23. doi: 10.1021/acs.molpharmaceut.5b00173. Epub 2015 Jul 3. Mol Pharm. 2015. PMID: 26065924 Free PMC article.

6

Honokiol suppresses lung tumorigenesis by targeting EGFR and its downstream effectors.

Song JM, Anandharaj A, Upadhyaya P, Kirtane AR, Kim JH, Hong KH, Panyam J, Kassie F. Song JM, et al. Among authors: kirtane ar. Oncotarget. 2016 Sep 6;7(36):57752-57769. doi: 10.18632/oncotarget.10759. Oncotarget. 2016. PMID: 27458163 Free PMC article.

7

Triptolide suppresses the in vitro and in vivo growth of lung cancer cells by targeting hyaluronan-CD44/RHAMM signaling.

Song JM, Molla K, Anandharaj A, Cornax I, O Sullivan MG, Kirtane AR, Panyam J, Kassie F. Song JM, et al. Among authors: kirtane ar. Oncotarget. 2017 Apr 18;8(16):26927-26940. doi: 10.18632/oncotarget.15879. Oncotarget. 2017. PMID: 28460475 Free PMC article.

8

Folic acid functionalized nanoparticles for enhanced oral drug delivery.

Roger E, Kalscheuer S, Kirtane A, Guru BR, Grill AE, Whittum-Hudson J, Panyam J. Roger E, et al. Mol Pharm. 2012 Jul 2;9(7):2103-10. doi: 10.1021/mp2005388. Epub 2012 Jun 13. Mol Pharm. 2012. PMID: 22670575 Free PMC article.

9

Chemopreventive efficacy of oral curcumin: a prodrug hypothesis.

Liu G, Khanna V, Kirtane A, Grill A, Panyam J. Liu G, et al. FASEB J. 2019 Aug;33(8):9453-9465. doi: 10.1096/fj.201900166R. Epub 2019 May 28. FASEB J. 2019. PMID: 31136203 Free PMC article.

10

Fibrinolytic Enzyme Cotherapy Improves Tumor Perfusion and Therapeutic Efficacy of Anticancer Nanomedicine.

Kirtane AR, Sadhukha T, Kim H, Khanna V, Koniar B, Panyam J. Kirtane AR, et al. Cancer Res. 2017 Mar 15;77(6):1465-1475. doi: 10.1158/0008-5472.CAN-16-1646. Epub 2017 Jan 20. Cancer Res. 2017. PMID: 28108516 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

39 results

Search Page

Filters